<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230111057111N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-26</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Investigating the effect of herbal and animal ointment in diabetic foot ulcer patients</public_title>
      <acronym></acronym>
      <scientific_title>Phase I&amp;II study of clinical trial safety and efficacy assessment of ointment made from extracted Shikonin in Alosa branschnikowi and Pusa capsica in patients with diabetic foot ulcers.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68030</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: in this research, in order to allocate patients to intervention and control groups, a block randomization approach will be used in a parallel way and random allocation rule. We will consider the size of the blocks randomly with a size of 4 or 6 , and various packages available in R software will be used to generate random numbers. The output of odd numbers will be classified in the intervention group and the output of even numbers will be classified in the control group. Allocation concealment method: There is no concealment.</study_design>
      <phase>1-2</phase>
      <hc_freetext>Diabetes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group received traditional treatment including washing twice a day with normal saline and keeping the wound clean and dry after that using the planned ointment twice a day for one month will be observed. The method of using the ointment is directly on the wound. The usual demographic information specified in the patient file is taken from the people, which includes: age, gender, occupation, education level, marital status, date and time, depth and percentage. Safety monitoring is verified by checklist in 4 stages (first day and 7, 14, 28), which includes evaluation of local and systemic side effects. Effective monitoring is done by the checklist taken from Fermin Digizaz's research called the scoring checklist system for the healing process of diabetic foot ulcers. The specialist will visit the patients to check the healing of the wound in 4 stages (the first, seventh, twenty-eighth, and sixtieth day).The presence of long-chain fats in the composition of the used fish oil keeps the wound moist and prevents the formation of scars during healing. This composition contains Eqiumrussicum plant consist of naphthoquinine and allantoin substances with the property of stimulating regeneration by rapid growth of the epidermis and mesoderm in honey base as a stimulant, antibiotic and stabilizer. Intervention 2: Control group: The control group received traditional treatment including washing twice a day with normal saline and keeping the wound clean and dry , and if necessary, bandaging with sterile gauze.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After deidentifying people, all the data obtained from the research, including the demographic information of the samples, clinical information and the results of the intervention can be shared.

When:
It is possible to access the results after nine to twelve months from the publication of the results.

To whom:
Researchers in academic centers and scientific research centers.

Conditions:
In order to data comparison in similar studies, the researchers of academic centers and scientific research centers have the possibility to receive data and re-analyze it if they comply with the principles of ethics in research.

Where to obtain:
Dr Mohammad Zaefizadeh with below email address: 
mzaefi@gmail.com	 and phone number +98 9144514378

How to obtain:
Researchers should send a written request to receive data to the relevant email address.A week after receiving an email , it will take action.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amin Bakhshizadeh Imcheh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.4 , Notash alley, Golmoghan bridge , Shahid barzegar street , Shohada highway</address>
        <city>Ardabil</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5616636316</zip>
        <telephone>+98 45 3342 3240</telephone>
        <email>bakhshizadeh.dr@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Mohammad Zaefizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Basij square</address>
        <city>Ardabil</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۵۶۱۵۷۳۱۵۶۷</zip>
        <telephone>+98 45 3342 3240</telephone>
        <email>mzaefi@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a chronic diabetic foot ulcer on an outpatient basis
Age range from 30 to 80 years
Having a single wound in the legs and extremities (fingers, soles, heels, on the toes) that has not healed for at least 4 weeks
Having a body mass index of 18-35</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The presence of a wound with an active infection requires receiving intravenous antibiotics
Gangrene requiring amputation
Smoking, alcohol and drug addiction
Taking drugs that may interfere with wound healing, such as corticosteroids, immunosuppressive agents, and cytotoxic agents.
Having concurrent disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>L97</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Ulcer of lower limb, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group received traditional treatment including washing twice a day with normal saline and keeping the wound clean and dry after that using the planned ointment twice a day for one month will be observed. The method of using the ointment is directly on the wound. The usual demographic information specified in the patient file is taken from the people, which includes: age, gender, occupation, education level, marital status, date and time, depth and percentage. Safety monitoring is verified by checklist in 4 stages (first day and 7, 14, 28), which includes evaluation of local and systemic side effects. Effective monitoring is done by the checklist taken from Fermin Digizaz's research called the scoring checklist system for the healing process of diabetic foot ulcers. The specialist will visit the patients to check the healing of the wound in 4 stages (the first, seventh, twenty-eighth, and sixtieth day).The presence of long-chain fats in the composition of the used fish oil keeps the wound moist and prevents the formation of scars during healing. This composition contains Eqiumrussicum plant consist of naphthoquinine and allantoin substances with the property of stimulating regeneration by rapid growth of the epidermis and mesoderm in honey base as a stimulant, antibiotic and stabilizer.</i_keyword>
      <i_keyword>Control group: The control group received traditional treatment including washing twice a day with normal saline and keeping the wound clean and dry , and if necessary, bandaging with sterile gauze.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Size of diabetic foot ulcer. Timepoint: Measurement of diabetic foot ulcer at the beginning of the study and then on days 7, 14 and 28. Method of measurement: Based on the examination by specialist and the checklist taken from Fermin Digizaz's research called the scoring checklist system for the healing process of diabetic foot ulcer.</prim_outcome>
      <prim_outcome>Local infection of diabetic foot ulcer. Timepoint: Investigation of wound infection at the beginning of the study and then on days 7, 14 and 28. Method of measurement: Based on the examination by specialist and the checklist taken from Fermin Digizaz's research called the scoring checklist system for the healing process of diabetic foot ulcer.</prim_outcome>
      <prim_outcome>Granulation tissue formation. Timepoint: Examination of granulation tissue formation at the beginning of the study and then on days 7, 14 and 28. Method of measurement: Based on the examination by specialist and the checklist taken from Fermin Digizaz's research called the scoring checklist system for the healing process of diabetic foot ulcer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The duration of complete healing of diabetic foot ulcer. Timepoint: At the beginning of the study and then on days 7, 14 ,28 and 60. Method of measurement: Based on the examination of the attending physician.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-20</approval_date>
        <contact_name>Research Ethics Committees of Islamic Azad University- Ardabil Branch</contact_name>
        <contact_address>Basij square Ardabil Ardabil Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
